Trademark Overview
On Monday, October 7, 2024, a trademark application was filed for O2LINE with the United States Patent and Trademark Office. The USPTO has given the O2LINE trademark a serial number of 98789168. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, April 22, 2025. This trademark is owned by PERSISTA BIO INC.. The O2LINE trademark is filed in the Medical Instrument Products category with the following description:
Surgical implants primarily consisting of artificial materials; surgical implants primarily comprising artificial materials; artificial tissues in the nature of surgical implants consisting of biological materials; biological tissues in the nature of surgical implants consisting of artificial materials; medical device surgical implants primarily comprised of artificial materials for cell therapy; medical device surgical implants primarily comprising artificial material for cell therapy; artificial biomaterial surgical implant for cell therapy; oxygen device surgical implants primarily comprising artificial material; oxygen device surgical implants primarily comprising artificial biomaterial; artificial biomaterial surgical implants for providing oxygen; artificial biomaterials drug delivery surgical implants; drug delivery surgical implants primarily comprising artificial materials; drug delivery surgical implants comprising artificial biomaterial; cell pouches; cell capsules
